574 related articles for article (PubMed ID: 32876667)
1. Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington's disease knock-in mice is blocked by Mlh1 knock-out.
Loupe JM; Pinto RM; Kim KH; Gillis T; Mysore JS; Andrew MA; Kovalenko M; Murtha R; Seong I; Gusella JF; Kwak S; Howland D; Lee R; Lee JM; Wheeler VC; MacDonald ME
Hum Mol Genet; 2020 Nov; 29(18):3044-3053. PubMed ID: 32876667
[TBL] [Abstract][Full Text] [Related]
2. FAN1 controls mismatch repair complex assembly via MLH1 retention to stabilize CAG repeat expansion in Huntington's disease.
Goold R; Hamilton J; Menneteau T; Flower M; Bunting EL; Aldous SG; Porro A; Vicente JR; Allen ND; Wilkinson H; Bates GP; Sartori AA; Thalassinos K; Balmus G; Tabrizi SJ
Cell Rep; 2021 Aug; 36(9):109649. PubMed ID: 34469738
[TBL] [Abstract][Full Text] [Related]
3. FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeat.
Goold R; Flower M; Moss DH; Medway C; Wood-Kaczmar A; Andre R; Farshim P; Bates GP; Holmans P; Jones L; Tabrizi SJ
Hum Mol Genet; 2019 Feb; 28(4):650-661. PubMed ID: 30358836
[TBL] [Abstract][Full Text] [Related]
4. FAN1, a DNA Repair Nuclease, as a Modifier of Repeat Expansion Disorders.
Deshmukh AL; Porro A; Mohiuddin M; Lanni S; Panigrahi GB; Caron MC; Masson JY; Sartori AA; Pearson CE
J Huntingtons Dis; 2021; 10(1):95-122. PubMed ID: 33579867
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing of individuals with Huntington's disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset.
McAllister B; Donaldson J; Binda CS; Powell S; Chughtai U; Edwards G; Stone J; Lobanov S; Elliston L; Schuhmacher LN; Rees E; Menzies G; Ciosi M; Maxwell A; Chao MJ; Hong EP; Lucente D; Wheeler V; Lee JM; MacDonald ME; Long JD; Aylward EH; Landwehrmeyer GB; Rosser AE; ; Paulsen JS; ; Williams NM; Gusella JF; Monckton DG; Allen ND; Holmans P; Jones L; Massey TH
Nat Neurosci; 2022 Apr; 25(4):446-457. PubMed ID: 35379994
[TBL] [Abstract][Full Text] [Related]
6. Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier Effects.
Kim KH; Hong EP; Shin JW; Chao MJ; Loupe J; Gillis T; Mysore JS; Holmans P; Jones L; Orth M; Monckton DG; Long JD; Kwak S; Lee R; Gusella JF; MacDonald ME; Lee JM
Am J Hum Genet; 2020 Jul; 107(1):96-110. PubMed ID: 32589923
[TBL] [Abstract][Full Text] [Related]
7. A modifier of Huntington's disease onset at the MLH1 locus.
Lee JM; Chao MJ; Harold D; Abu Elneel K; Gillis T; Holmans P; Jones L; Orth M; Myers RH; Kwak S; Wheeler VC; MacDonald ME; Gusella JF
Hum Mol Genet; 2017 Oct; 26(19):3859-3867. PubMed ID: 28934397
[TBL] [Abstract][Full Text] [Related]
8. Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington's disease mice: genome-wide and candidate approaches.
Pinto RM; Dragileva E; Kirby A; Lloret A; Lopez E; St Claire J; Panigrahi GB; Hou C; Holloway K; Gillis T; Guide JR; Cohen PE; Li GM; Pearson CE; Daly MJ; Wheeler VC
PLoS Genet; 2013 Oct; 9(10):e1003930. PubMed ID: 24204323
[TBL] [Abstract][Full Text] [Related]
9. A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease.
Aldous SG; Smith EJ; Landles C; Osborne GF; Cañibano-Pico M; Nita IM; Phillips J; Zhang Y; Jin B; Hirst MB; Benn CL; Bond BC; Edelmann W; Greene JR; Bates GP
Brain; 2024 May; 147(5):1784-1798. PubMed ID: 38387080
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease.
Wright GEB; Caron NS; Ng B; Casal L; Casazza W; Xu X; Ooi J; Pouladi MA; Mostafavi S; Ross CJD; Hayden MR
Hum Mol Genet; 2020 Sep; 29(16):2788-2802. PubMed ID: 32898862
[TBL] [Abstract][Full Text] [Related]
11. FAN1 exo- not endo-nuclease pausing on disease-associated slipped-DNA repeats: A mechanism of repeat instability.
Deshmukh AL; Caron MC; Mohiuddin M; Lanni S; Panigrahi GB; Khan M; Engchuan W; Shum N; Faruqui A; Wang P; Yuen RKC; Nakamori M; Nakatani K; Masson JY; Pearson CE
Cell Rep; 2021 Dec; 37(10):110078. PubMed ID: 34879276
[TBL] [Abstract][Full Text] [Related]
12. Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington's Disease Knock-In Mice.
Neto JL; Lee JM; Afridi A; Gillis T; Guide JR; Dempsey S; Lager B; Alonso I; Wheeler VC; Pinto RM
Genetics; 2017 Feb; 205(2):503-516. PubMed ID: 27913616
[TBL] [Abstract][Full Text] [Related]
13. Posttranscriptional regulation of
Kim KH; Hong EP; Lee Y; McLean ZL; Elezi E; Lee R; Kwak S; McAllister B; Massey TH; Lobanov S; Holmans P; Orth M; Ciosi M; Monckton DG; Long JD; Lucente D; Wheeler VC; MacDonald ME; Gusella JF; Lee JM
Proc Natl Acad Sci U S A; 2024 Apr; 121(16):e2322924121. PubMed ID: 38607933
[TBL] [Abstract][Full Text] [Related]
14. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice.
Kovalenko M; Dragileva E; St Claire J; Gillis T; Guide JR; New J; Dong H; Kucherlapati R; Kucherlapati MH; Ehrlich ME; Lee JM; Wheeler VC
PLoS One; 2012; 7(9):e44273. PubMed ID: 22970194
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease.
Ferguson R; Goold R; Coupland L; Flower M; Tabrizi SJ
Am J Hum Genet; 2024 Jun; 111(6):1165-1183. PubMed ID: 38749429
[TBL] [Abstract][Full Text] [Related]
16. Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.
Wright GEB; Black HF; Collins JA; Gall-Duncan T; Caron NS; Pearson CE; Hayden MR
Lancet Neurol; 2020 Nov; 19(11):930-939. PubMed ID: 33098802
[TBL] [Abstract][Full Text] [Related]
17. A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes.
Ciosi M; Maxwell A; Cumming SA; Hensman Moss DJ; Alshammari AM; Flower MD; Durr A; Leavitt BR; Roos RAC; ; ; Holmans P; Jones L; Langbehn DR; Kwak S; Tabrizi SJ; Monckton DG
EBioMedicine; 2019 Oct; 48():568-580. PubMed ID: 31607598
[TBL] [Abstract][Full Text] [Related]
18. Modifiers of Somatic Repeat Instability in Mouse Models of Friedreich Ataxia and the Fragile X-Related Disorders: Implications for the Mechanism of Somatic Expansion in Huntington's Disease.
Zhao X; Kumari D; Miller CJ; Kim GY; Hayward B; Vitalo AG; Pinto RM; Usdin K
J Huntingtons Dis; 2021; 10(1):149-163. PubMed ID: 33579860
[TBL] [Abstract][Full Text] [Related]
19. Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's disease.
Choi DE; Shin JW; Zeng S; Hong EP; Jang JH; Loupe JM; Wheeler VC; Stutzman HE; Kleinstiver B; Lee JM
Elife; 2024 Jun; 12():. PubMed ID: 38869243
[TBL] [Abstract][Full Text] [Related]
20. CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset.
;
Cell; 2019 Aug; 178(4):887-900.e14. PubMed ID: 31398342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
